How would you like your name to appear on your certificate?

The program was relevant to my work.

Usefulness of handouts/AV/technology.

Quality of facilities/facility accomodations or website/accessibility, if online.

How well did the educational sessions give a balanced view of therapeutic options, including the use of generic names?

If you rated any of the above questions with 'fair,' 'poor,' 'disagree,' or 'strongly disagree' please explain in detail (e.g. session title, speaker name, situation):

Please rate the speaker(s) of this session as a group. You will have the opportunity to elaborate on an individual speaker in the following question. 

If you have additional comments regarding the session or individual speaker(s) - e.g. content issues, teaching ability, credentials or expertise, etc. - please use the space below:

1. Understand the Clinical Presentation and Diagnosis of DID.

2. Identify the diagnostic criteria for Dissociative Identity Disorder (DID) as outlined in the DSM-5.

3. Recognize the common comorbidities associated with DID, including eating disorders and other major psychiatric conditions.

4. Analyze the impact of early and severe child maltreatment in the development of DID.

5. Improve Diagnostic Accuracy and Treatment Approaches Assess the importance of accurate diagnosis of DID to preventmisdiagnosis and inappropriate treatment.

6. Evaluate evidence-based psychotherapeutic strategies for treating DID, focusing on case studies and clinical researchfi ndings.

7. Develop skills to implement integrative treatment plans that address the complex needs of patients with DID.

8. Enhance Clinical Skills through Case-Based Learning.

9. Apply theroretical knowledge of DID to practical clinical scenarios through an in-depth case presentation.

10. Observe and critique video clips of actual therapy sessions to udnerstand the therapeutic process and techniques used over a 4.5-year treatment period.

11. Reflect on the challenges and successes of long-term psychotherapy in achieving full integration for patients with DID.

If you disagreed, please tell us why:

Did this program improve your Skill or Strategy in your role or contribution as a member of the healthcare team?

Please explain how, or why not?

Was the educational content scientifically sound?

If faculty spoke about off-label or investigational uses of a product, was that information disclosed to you?

Was the mode of education effective to learning?

If you resonded "No" to any of the preceding questions, please explain why:

Did you perceive any commercial bias or influence in the educational content?

If you answered "Yes" to the above question, please detail the situation below (e.g. session title, speaker name):

Were you solicited by sales personnel in an educational area (other areas do not matter) while you attended this educational activity?

If you answered "Yes" to the above question, please explain in detail (e.g. who, when, where):

Do you believe your participation in this activity will positively impact your healthcare team?

Why, or why not?

What questions are you having in your practice that you would like to see addressed in an educational activity?

What barriers might you have that would interfere with implementation of new information learned from this training?

How can this training (the overall meeting) be improved to better impact knowledge, strategies/skills, performance and/or patient outcomes?

Additional comments: